Publication | Open Access

TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms

NeuropsychologyPsychoactive DrugPsychiatryMultiple ParadigmsMedicinePde10a InhibitorPsychopharmacologySchizophreniaNeuropharmacologyNeuropsychiatryNeuroscienceBiological PsychiatryPharmacologyIndirect PathwaysSocial Sciences